Maze Therapeutics, Inc. Common Stock (MAZE) — Capital Reinvestment Ratio
Maze Therapeutics, Inc. Common Stock (MAZE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($145.05 Million) in capital expenditures ($160.00K). Check MAZE tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Maze Therapeutics, Inc. Common Stock Capital Reinvestment Ratio (2024–2024)
This chart tracks Maze Therapeutics, Inc. Common Stock's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Maze Therapeutics, Inc. Common Stock cash conversion from operations.
Annual Capital Reinvestment Ratio for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year Capital Reinvestment Ratio for Maze Therapeutics, Inc. Common Stock from 2024 to 2024. See how much free cash does Maze Therapeutics, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | $75.95 Million | $1.15 Million | — |